BG
NGNE icon

BlackRock Group’s Neurogene NGNE Stock Holding History

BlackRock Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.83M Hold
11,600
– – ﹤0.01% 1337
2016
Q3 		$3.1M Buy
11,600
+1,595
+16% +$322K ﹤0.01% 1345
2016
Q2 		$1.32M Hold
10,005
– – ﹤0.01% 1812
2016
Q1 		$1.76M Buy
10,005
+1,895
+23% +$368K ﹤0.01% 1621
2015
Q4 		$2.02M Hold
8,110
– – ﹤0.01% 1477
2015
Q3 		$2.28M Buy
8,110
+5,590
+222% +$1.29M ﹤0.01% 1423
2015
Q2 		$350K Hold
2,520
– – ﹤0.01% 2394
2015
Q1 		$414K Buy
2,520
+80
+3% +$16.3K ﹤0.01% 2265
2014
Q4 		$366K Hold
2,440
– – ﹤0.01% 2339
2014
Q3 		$325K Hold
2,440
– – ﹤0.01% 2316
2014
Q2 		$460K Hold
2,440
– – ﹤0.01% 2234
2014
Q1 		$621K Buy
+2,440
New +$627K ﹤0.01% 2170

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Group's NGNE Position: Q4 2016 in Review

BlackRock Group held its Neurogene (NGNE) position steady in Q4 2016 at 11,600 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

BlackRock Group first reported a position in NGNE in Q1 2014 and has held it in 12 quarters since. 49 funds tracked by Wall St. Rank hold NGNE as of Q4 2016.

  • BlackRock Group held 11,600 shares of Neurogene worth $3.83M as of Q4 2016.
  • BlackRock Group left its Neurogene share count unchanged in Q4 2016.
  • Neurogene made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1337 holding.
  • BlackRock Group first reported a position in Neurogene in Q1 2014 and has held it in 12 quarters since.
  • 49 funds tracked by Wall St. Rank held Neurogene as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.